BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Austad SN, Ballinger S, Buford TW, Carter CS, Smith DL Jr, Darley-Usmar V, Zhang J. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease. Acta Pharm Sin B 2022;12:511-31. [PMID: 35256932 DOI: 10.1016/j.apsb.2021.06.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Yu C, Yao Y, Lai H, Ye X, Xu J, Guo J, Xiao X, Lin C, Huang Z, Lin J, Yu C, Zha D. Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease. Eur J Med Chem 2023;248:115120. [PMID: 36682173 DOI: 10.1016/j.ejmech.2023.115120] [Reference Citation Analysis]
2 Stefanova NA, Kolosova NG. The Rat Brain Transcriptome: From Infancy to Aging and Sporadic Alzheimer's Disease-like Pathology. Int J Mol Sci 2023;24. [PMID: 36674977 DOI: 10.3390/ijms24021462] [Reference Citation Analysis]
3 Grünblatt E, Homolak J, Babic Perhoc A, Davor V, Knezovic A, Osmanovic Barilar J, Riederer P, Walitza S, Tackenberg C, Salkovic-Petrisic M. From attention-deficit hyperactivity disorder to sporadic Alzheimer's disease-Wnt/mTOR pathways hypothesis. Front Neurosci 2023;17:1104985. [PMID: 36875654 DOI: 10.3389/fnins.2023.1104985] [Reference Citation Analysis]
4 Atlante A, Amadoro G, Latina V, Valenti D. Therapeutic Potential of Targeting Mitochondria for Alzheimer's Disease Treatment. J Clin Med 2022;11. [PMID: 36431219 DOI: 10.3390/jcm11226742] [Reference Citation Analysis]
5 Huynh VN, Wang S, Ouyang X, Wani WY, Johnson MS, Chacko BK, Jegga AG, Qian WJ, Chatham JC, Darley-Usmar VM, Zhang J. Defining the Dynamic Regulation of O-GlcNAc Proteome in the Mouse Cortex---the O-GlcNAcylation of Synaptic and Trafficking Proteins Related to Neurodegenerative Diseases. Front Aging 2021;2:757801. [PMID: 35822049 DOI: 10.3389/fragi.2021.757801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ma W, Xu D, Zhao L, Yuan M, Cui YL, Li Y. Therapeutic role of curcumin in adult neurogenesis for management of psychiatric and neurological disorders: a scientometric study to an in-depth review. Crit Rev Food Sci Nutr 2022;:1-13. [PMID: 35482938 DOI: 10.1080/10408398.2022.2067827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Benavides GA, Mueller T, Darley-usmar V, Zhang J. Optimization of measurement of mitochondrial electron transport activity in postmortem human brain samples and measurement of susceptibility to rotenone and 4-hydroxynonenal inhibition. Redox Biology 2022;50:102241. [DOI: 10.1016/j.redox.2022.102241] [Reference Citation Analysis]
8 Ding W, Swerdlow RH. Editorial of special column on Drug targets and drug development for Alzheimer's disease. Acta Pharmaceutica Sinica B 2022;12:1686-7. [DOI: 10.1016/j.apsb.2022.03.007] [Reference Citation Analysis]
9 Dodson M, Benavides GA, Darley-usmar V, Zhang J. Differential Effects of 2-Deoxyglucose and Glucose Deprivation on 4-Hydroxynonenal Dependent Mitochondrial Dysfunction in Primary Neurons. Front Aging 2022;3. [DOI: 10.3389/fragi.2022.812810] [Reference Citation Analysis]
10 Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Steliou K, Tamvakopoulos C, Vavvas DG, Zamboni RJ, Sampani K. Pathogenic mitochondrial dysfunction and metabolic abnormalities. Biochem Pharmacol 2021;193:114809. [PMID: 34673016 DOI: 10.1016/j.bcp.2021.114809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]